Authors: Scientific Committee SCCS (European Commission, Directorate General for Health and Food Safety, Luxembourg), Coenraads, P.-J. (University Medical Center Groningen, Groningen, The Netherlands)
References: Regulatory Toxicology and Pharmacology (2015)
Received 28.07.2015, accepted 29.07.2015, In Press
SCCS Opinion of reference:
SCCS/1526/14 “Opinion on peanut oil (sensitisation only)”
adopted 27.03.2014, revised 23.09.2014
Conclusion : “there is no known safe threshold currently defined at which the skin of peanut allergic subjects can safely be exposed to peanut proteins, although such thresholds are available for oral intake.
The SCCS has followed the scientific debate about the importance of skin exposure as a route for induction of sensitisation to type I allergens such as peanut. The SCCS acknowledges that this is of concern, but that there are insufficient data to define a safe level of skin exposure in the non-sensitised population.
However, in view of the documented safe levels of oral intake of peanut protein in sensitised individuals and in view of the industry’s capability to refine peanut oil below a protein level of 0.5 ppm, the SCCS can accept this value as maximum allowable concentration in (refined) peanut oil for cosmetic use.”
Cet article n’engage que son auteur/ This article is the sole responsibility of the author.